Family Medicine · Bedford, TX
NPI
1154524668
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1305 Airport Fwy Ste 302
Bedford, TX, 76021
Phone (817) 283-6995
Groups this clinician bills Medicare through
Medicare paid, 2024
$369K
15,022 services
Medicare patients, 2024
294
Average age 71
Drug cost, 2024
$975K
9,723 prescriptions
Company payments, 2025
$2,508
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rodolfo A Herrera was code J1010 (injection, methylprednisolone acetate, 1 mg), 6,308 times for 54 patients. In total Rodolfo A Herrera billed 15,022 services in 95 codes, and Medicare paid $369K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 6,308 | 54 | $0.10 | $624 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 907 | 62 | $36.94 | $34K |
| 99484 Behavioral Health Services | Office | 515 | 142 | $39.99 | $21K |
| 99213 Office E&M - Established | Office | 500 | 130 | $65.99 | $33K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 474 | 61 | $46.54 | $22K |
| 99458 E&M - Miscellaneous | Office | 466 | 59 | $30.49 | $14K |
| 99214 Office E&M - Established | Office | 357 | 153 | $80.65 | $29K |
| 99427 Chronic, Principal, and Transitional Care Management | Office | 326 | 22 | $35.95 | $12K |
| 80307 Drug Tests | Office | 307 | 135 | $59.37 | $18K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 296 | 29 | $0.73 | $215 |
| 99454 E&M - Miscellaneous | Office | 282 | 62 | $36.86 | $10K |
| 99457 E&M - Miscellaneous | Office | 282 | 64 | $38.10 | $11K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 244 | 98 | $108.55 | $26K |
| G3002 Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 193 | 113 | $52.83 | $10K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 176 | 22 | $47.13 | $8,295 |
By year: 2022 $129K for 3,916 services; 2023 $229K for 9,546 services; 2024 $369K for 15,022 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 307 | 135 | $59.37 | $18K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 244 | 98 | $108.55 | $26K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 50 | 50 | $241.98 | $12K |
| 36415 Venipuncture Blood Collection | 15 | 12 | $4.67 | $70.08 |
Medicare prescription drug claims, 2024
In 2024, the drug Rodolfo A Herrera prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 2,870 prescriptions and refills. In total Rodolfo A Herrera wrote 9,723 Medicare prescriptions that cost $975K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,870 | 2,870 | 401 | $106K |
| Buprenorphine Generic | 560 | 560 | 119 | $137K |
| Gabapentin Generic | 555 | 642 | 137 | $7,799 |
| Pregabalin Generic | 549 | 581 | 137 | $13K |
| Cyclobenzaprine Hcl Generic | 423 | 494 | 99 | $13K |
| Tizanidine Hcl Generic | 416 | 448 | 114 | $4,878 |
| Celecoxib Generic | 398 | 428 | 119 | $6,896 |
| Oxycodone Hcl Generic | 250 | 250 | 49 | $4,065 |
| Diazepam Generic | 229 | 229 | 117 | $211 |
| Lidocaine Generic | 210 | 338 | 60 | $38K |
| Methocarbamol Generic | 200 | 213 | 45 | $3,337 |
| Tramadol Hcl Generic | 191 | 192 | 75 | $1,646 |
| Belbuca Buprenorphine Hcl | 169 | 170 | 41 | $135K |
| Quetiapine Fumarate Generic | 169 | 185 | 49 | $1,304 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 167 | 167 | 31 | $6,699 |
Brand drugs: - claims; generic drugs: 9,037 claims; opioid claims: 4,811.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rodolfo A Herrera $2,508 ($2,508 in general payments such as food, travel and fees) from 25 companies. The largest payer was Spinal Simplicity, LLC with $1,411.
| Company | Payments | Amount |
|---|---|---|
| Spinal Simplicity, LLC | 20 | $1,411 |
| Abbott Laboratories ABT | 11 | $337 |
| Novo Nordisk Inc NVO | 6 | $103 |
| Vertex Pharmaceuticals Incorporated VRTX | 4 | $97.38 |
| Abbvie Inc. ABBV | 3 | $69.07 |
| Averitas Pharma Inc. | 2 | $62.73 |
| Genzyme Corporation SNY | 1 | $57.94 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $46.34 |
| Collegium Pharmaceutical, Inc. COLL | 2 | $38.14 |
| Nalu Medical, Inc. | 2 | $37.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.